Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-009066

CVP, JAPAC sold 1,020 shares at $82.55 ($84,196)

  • CVP, JAPAC acquired 1,020 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lippis Daniel J. · CVP, JAPAC

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-10 Exercise or conversion : show line 1 in the form 10b5-1 +1,020 $59.26 $60,442 23,021.91 D
2025-11-10 Sale : show line 2 in the form 10b5-1 −1,020 $82.55 $84,196 22,001.91 D
Open-market sales · 1,020 sh · avg $82.55 · $84,196

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-10 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −1,020 6,114 D
Loading xslF345X05/doc4.xml…